Deep Track Capital, LP 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Deep Track Capital, LP disclosed 69 US equity positions worth $3.1bn in its Q1 2025 13F filing. The largest position was ITCIEUR at 8.5% of the reported book, followed by GH and DVAX. Against the Q4 2024 filing, it opened 12 new positions, added to 22 and reduced 4 among the top 50 holdings.
What did Deep Track Capital, LP own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 8.5% | $263.8m | 2,000,000 | 0% | held | |
| 2 | GH GUARDANT HEALTH INC | Healthcare | 7.5% | $231.9m | 5,443,721 | -15% | reduced |
| 3 | DVAX DYNAVAX TECHNOLOGIES CORP | 7.5% | $230.8m | 17,791,486 | 0% | held | |
| 4 | IMVT IMMUNOVANT INC | Healthcare | 5.3% | $162.4m | 9,500,000 | 58% | added |
| 5 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 4.7% | $145.1m | 3,000,000 | 200% | added |
| 6 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 4.5% | $137.7m | 4,564,207 | 136% | added |
| 7 | AKERO THERAPEUTICS INC | 4.2% | $130.0m | 3,210,270 | 115% | added | |
| 8 | CYTK CYTOKINETICS INC | Healthcare | 4.0% | $123.5m | 3,073,853 | 23% | added |
| 9 | APLSUSD APELLIS PHARMACEUTICALS INC | 3.5% | $109.3m | 5,000,000 | 17% | added | |
| 10 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.4% | $104.8m | 14,294,420 | 11% | added |
| 11 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.1% | $96.8m | 2,800,000 | 242% | added |
| 12 | TARS TARSUS PHARMACEUTICALS INC | Healthcare | 2.5% | $76.2m | 1,484,266 | – | new |
| 13 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 2.3% | $72.5m | 5,380,449 | 19% | added |
| 14 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 2.3% | $71.0m | 4,100,000 | 46% | added |
| 15 | ETNBGBP 89BIO INC | 2.2% | $67.7m | 9,316,333 | 44% | added | |
| 16 | NRIX NURIX THERAPEUTICS INC | Healthcare | 2.1% | $65.3m | 5,500,000 | 83% | added |
| 17 | GERN GERON CORP | Healthcare | 2.0% | $60.7m | 38,176,251 | 852% | added |
| 18 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 1.9% | $57.4m | 899,731 | – | new |
| 19 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.6% | $48.9m | 1,350,000 | 107% | added |
| 20 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.5% | $46.9m | 700,000 | 8% | added |
| 21 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.4% | $42.8m | 2,357,702 | – | new |
| 22 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 1.4% | $41.9m | 1,411,402 | 172% | added |
| 23 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.2% | $36.3m | 2,000,000 | 30% | added |
| 24 | MAZE MAZE THERAPEUTICS INC | 1.2% | $36.0m | 3,269,126 | – | new | |
| 25 | AMGN AMGEN INC | Healthcare | 1.1% | $35.2m | 113,035 | – | new |
| 26 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.1% | $33.5m | 1,000,000 | 491% | added |
| 27 | EWTX EDGEWISE THERAPEUTICS INC | 1.0% | $30.8m | 1,400,000 | 97% | added | |
| 28 | METSERA INC | 1.0% | $29.8m | 1,094,408 | – | new | |
| 29 | PCVX VAXCYTE INC | Healthcare | 0.9% | $28.3m | 750,000 | – | new |
| 30 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.9% | $27.7m | 17,849,482 | 26% | added |
| 31 | BCAX BICARA THERAPEUTICS INC | 0.8% | $26.1m | 2,000,000 | 0% | held | |
| 32 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.8% | $25.3m | 8,859,648 | – | new |
| 33 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.8% | $24.8m | 1,401,938 | – | new |
| 34 | ABVX ABIVAX SA | 0.7% | $22.4m | 3,579,209 | 0% | held | |
| 35 | MBX MBX BIOSCIENCES INC | Healthcare | 0.7% | $22.3m | 3,018,935 | 0% | held |
| 36 | GHRS GH RESEARCH PLC | 0.7% | $22.1m | 2,000,000 | – | new | |
| 37 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.7% | $20.9m | 2,000,000 | 0% | held |
| 38 | ENGENE HOLDINGS INC | 0.7% | $20.4m | 4,557,575 | 0% | held | |
| 39 | INSM INSMED INC | Healthcare | 0.6% | $19.4m | 254,751 | – | new |
| 40 | LKFT GALAPAGOS NV | Healthcare | 0.6% | $18.6m | 741,068 | -5% | reduced |
| 41 | SG7 SAGE THERAPEUTICS INC | 0.5% | $16.2m | 2,038,845 | – | new | |
| 42 | 430 TERNS PHARMACEUTICALS INC | 0.5% | $15.4m | 5,576,558 | 0% | held | |
| 43 | KRRO KORRO BIO INC | Healthcare | 0.5% | $15.2m | 874,614 | 0% | held |
| 44 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 0.5% | $14.8m | 1,444,709 | 93% | added |
| 45 | BRD1EUR MIND MEDICINE MINDMED INC | 0.5% | $14.6m | 2,500,000 | -11% | reduced | |
| 46 | UPB UPSTREAM BIO INC | 0.5% | $14.1m | 2,299,567 | 130% | added | |
| 47 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 0.4% | $12.9m | 3,442,833 | 0% | held |
| 48 | SEPN SEPTERNA INC | 0.4% | $11.1m | 1,912,929 | 0% | held | |
| 49 | NVAX NOVAVAX INC | Healthcare | 0.3% | $9.7m | 1,518,182 | -24% | reduced |
| 50 | HELP CYBIN INC | 0.3% | $9.7m | 1,529,987 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.